Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis

Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis

Our previous studies have demonstrated that Enzalutamide-induced upregulation of long non-coding RNA p21 (lncRNA-p21) facilitates prostate cancer (PCa) neuroendocrine differentiation (NED). Given the important role of lncRNAs in PCa pathogenesis, and given that lots of lncRNAs are dys-regulated in n...

Full description

Bibliographic Details
Main Authors: Bo Liu, Hui-Yang Jiang, Tao Yuan, Jie Luo, Wei-Dong Zhou, Qi-Quan Jiang, Denglong Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
neuroendocrine differentiation
PCAT6
miR-326
HNRNPA2B1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.650054/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.650054/full

Similar Items